Boisson-Walsh Alix, Ngimbi Patrick, Morgan Camille E, Stover Angela M, Mbonze Nana, Ntambua Sarah, Matondo Jolie, Yotebieng Marcel, Kashamuka Melchior M, James Linda, Parr Jonathan B, Mampunza Samuel, Thompson Peyton
Division of Infectious Diseases, Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina, United States of America.
Faculté de Médecine, Université Protestante au Congo, Kinshasa, Democratic Republic of the Congo.
PLOS Glob Public Health. 2025 Jul 16;5(7):e0004755. doi: 10.1371/journal.pgph.0004755. eCollection 2025.
The COVID-19 pandemic negatively impacted routine immunizations worldwide, decreasing confidence in vaccination programs. We used mixed methods to examine changes in vaccine confidence from before to during the pandemic in HBV-negative adults in Kinshasa who were exposed to HBV in the household, and eligible for HBV vaccination. We measured changes in routine HBV vaccine confidence with a previously validated Shift in Vaccine Confidence (SVC) self-report measure that was verbally administered in Lingala (local language). We compared vaccination confidence before versus during the pandemic using Chi-square tests. We also interviewed participants and coded open-ended responses to the SVC scale to explore context-specific perceptions. From April 2022 to February 2023, we administered the SVC tool to a purposive sample of 41 participants: 7 vaccinees, 23 willing to receive HBV vaccine, and 11 refusers. Participants had a median age of 32 years, were predominantly affiliated with Revivalist churches, and most reported unemployment and no education beyond secondary school. We observed statistically significant declines across all five vaccine confidence domains when comparing responses before and during the pandemic (p < 0.01): vaccines prevent diseases (85.4%-68.3%), are safe (80.5%-46.3%), important for a child's health (92.7%-87.8%) and one's own health (87.8%-68.3%), and new vaccines carry no more risk than routine vaccines (78.1%-63.5%). Qualitative analysis identified four themes impacting uptake decisions: vaccine confidence, knowledge, risks, and external influences. Rising uncertainty about efficacy, safety, and distrust in the COVID-19 vaccine undermined vaccine confidence among our participants. Factors such as distrust in manufacturers and government, fear of side effects, perceived low illness risk, and inconvenient healthcare access contributed to low vaccine uptake. These insights underscore the pandemic's impact on routine immunization and emphasize the need for consideration in future vaccination campaigns.
新冠疫情对全球常规免疫接种产生了负面影响,降低了人们对疫苗接种计划的信心。我们采用混合方法,研究了金沙萨家庭中接触过乙肝病毒且有资格接种乙肝疫苗的乙肝阴性成年人在疫情前至疫情期间疫苗信心的变化。我们使用先前验证过的疫苗信心转变(SVC)自我报告测量方法来衡量常规乙肝疫苗信心的变化,该方法以林加拉语(当地语言)进行口头施测。我们使用卡方检验比较了疫情前和疫情期间的疫苗接种信心。我们还对参与者进行了访谈,并对SVC量表的开放式回答进行编码,以探索特定背景下的看法。2022年4月至2023年2月,我们对41名参与者进行了有目的抽样,施测SVC工具:7名已接种疫苗者、23名愿意接种乙肝疫苗者和11名拒绝者。参与者的年龄中位数为32岁,主要隶属于复兴派教会,大多数人报告失业且没有接受过中学以上教育。在比较疫情前和疫情期间的回答时,我们观察到所有五个疫苗信心领域都有统计学上的显著下降(p < 0.01):疫苗预防疾病(85.4%-68.3%)、安全(80.5%-46.3%)、对儿童健康重要(92.7%-87.8%)和对自身健康重要(87.8%-68.3%),以及新疫苗的风险不高于常规疫苗(78.1%-63.5%)。定性分析确定了影响接种决策的四个主题:疫苗信心、知识、风险和外部影响。对新冠疫苗效力、安全性的不确定性增加以及对其的不信任削弱了我们参与者的疫苗信心。对制造商和政府的不信任、对副作用的恐惧、认为患病风险低以及医疗服务获取不便等因素导致疫苗接种率较低。这些见解强调了疫情对常规免疫接种的影响,并强调了在未来疫苗接种运动中需要加以考虑。